IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.30M	$50.51M	-
CFO	Girao Tiago	247.6K	$9.62M	-10,000
COO	Gloria Melanie	224.4K	$8.72M	-17,714
Other	Stout Jay S	218.4K	$8.49M	-40,000
Other	Geffner Michael	218.0K	$8.47M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 2, 2024	Pande Atul74	Director	Sell	7,750	$28.54	$221,185.00	-8.2%	-35.9%	-23.5%
Nov 20, 2024	Levine Mark S.66	Chief Legal Officer	Sell	3,650	$25.45	$92,892.50	-1.1%	-20.4%	-12.9%
Nov 20, 2024	MacIas William L.51	Chief Medical Officer	Sell	3,353	$25.45	$85,333.85	-0.9%	-20.4%	-12.9%
Nov 20, 2024	Barnett Eva Renee58	Chief Financial Officer	Sell	4,174	$25.45	$106,228.30	-1.2%	-20.4%	-12.9%
Nov 20, 2024	Salzmann Peter51	Chief Executive Officer	Sell	16,692	$25.45	$424,811.40	-1.7%	-20.4%	-12.9%
Oct 23, 2024	Levine Mark S.66	Chief Legal Officer	Sell	4,361	$29.53	$128,780.33	-1.3%	-21.4%	-37.6%
Oct 23, 2024	Geffner Michael66	Chief Medical Officer	Sell	3,189	$29.53	$94,171.17	-2.3%	-21.4%	-37.6%
Oct 23, 2024	Stout Jay S63	Chief Technology Officer	Sell	2,740	$29.53	$80,912.20	-1.9%	-21.4%	-37.6%
Oct 16, 2024	Salzmann Peter51	Chief Executive Officer	Sell	9,095	$28.79	$261,845.05	-0.9%	-21.6%	-40.3%
Oct 16, 2024	MacIas William L.51	Chief Medical Officer	Sell	3,188	$28.79	$91,782.52	-0.4%	-21.6%	-40.3%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC